Oxeia Biopharmaceuticals, Inc.
Pharmaceutical company · Boston, Massachusetts, United States
Oxeia Biopharmaceuticals, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $310,000 sold in a notice filed in 2014.
Oxeia Biopharmaceuticals at a glance
What does Oxeia Biopharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $310,000 sold (2014).
Frequently asked questions about Oxeia Biopharmaceuticals
Where is Oxeia Biopharmaceuticals headquartered?
Oxeia Biopharmaceuticals, Inc. is headquartered in Boston, Massachusetts, United States.
What does Oxeia Biopharmaceuticals do?
Oxeia Biopharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Oxeia Biopharmaceuticals founded?
The earliest incorporation on record for Oxeia Biopharmaceuticals, Inc. is in 2014, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences